Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Arnold Monto

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Human Influenza

Chemicals & Drugs

Living Beings

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Monto Arnold S; Ohmit Suzanne E; Petrie Joshua G; Johnson Emileigh; Truscon Rachel; Teich Esther; Rotthoff Judy; Boulton Matthew; Victor John C
Comparative efficacy of inactivated and live attenuated influenza vaccines.
Monto Arnold S; Ansaldi Filippo; Aspinall Richard; McElhaney Janet E; Montaño Luis F; Nichol Kristin L; Puig-Barberà Joan; Schmitt Joe; Stephenson Iain
Influenza control in the 21st century: Optimizing protection of older adults.
Uyeki Timothy M; Prasad Ramakrishna; Vukotich Charles; Stebbins Samuel; Rinaldo Charles R; Ferng Yu-Hui; Morse Stephen S; Larson Elaine L; Aiello Allison E; Davis Brian; Monto Arnold S
Low sensitivity of rapid diagnostic test for influenza.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Arnold Monto (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Monto Arnold S; Ohmit Suzanne E; Petrie Joshua G; Johnson Emileigh; Truscon Rachel; Teich Esther; Rotthoff Judy; Boulton Matthew; Victor John C
Comparative efficacy of inactivated and live attenuated influenza vaccines.
The New England journal of medicine 2009;361(13):1260-7.
2009: Monto Arnold S; Ansaldi Filippo; Aspinall Richard; McElhaney Janet E; Montaño Luis F; Nichol Kristin L; Puig-Barberà Joan; Schmitt Joe; Stephenson Iain
Influenza control in the 21st century: Optimizing protection of older adults.
Vaccine 2009;27(37):5043-53.
2009: Uyeki Timothy M; Prasad Ramakrishna; Vukotich Charles; Stebbins Samuel; Rinaldo Charles R; Ferng Yu-Hui; Morse Stephen S; Larson Elaine L; Aiello Allison E; Davis Brian; Monto Arnold S
Low sensitivity of rapid diagnostic test for influenza.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(9):e89-92.
2009: Monto Arnold S; Ohmit Suzanne E
Seasonal influenza vaccines: evolutions and future trends.
Expert review of vaccines 2009;8(4):383-9.
2009: Layne Scott P; Monto Arnold S; Taubenberger Jeffery K
Pandemic influenza: an inconvenient mutation.
Science (New York, N.Y.) 2009;323(5921):1560-1.
2009: Monto Arnold S
Implications of antiviral resistance of influenza viruses.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(4):397-9.
2009: Ohmit Suzanne E; Gross Jonathan; Victor John C; Monto Arnold S
Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination.
Vaccine 2009;27(7):1050-4.
2009: Monto Arnold S
The risk of seasonal and pandemic influenza: prospects for control.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48 Suppl 1():S20-5.
2008: Jennings Lance C; Monto Arnold S; Chan Paul K S; Szucs Thomas D; Nicholson Karl G
Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans.
The Lancet infectious diseases 2008;8(10):650-8.
2008: Monto Arnold S
Antivirals and influenza: frequency of resistance.
The Pediatric infectious disease journal 2008;27(10 Suppl):S110-2.
2008: Monto Arnold S
Epidemiology of influenza.
Vaccine 2008;26 Suppl 4():D45-8.
2008: Monto Arnold S
Editorial commentary: viral susceptibility and the choice of influenza antivirals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(3):346-8.
2008: Ohmit Suzanne E; Victor John C; Teich Esther R; Truscon Rachel K; Rotthoff Judy R; Newton Duane W; Campbell Sarah A; Boulton Matthew L; Monto Arnold S
Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines.
The Journal of infectious diseases 2008;198(3):312-7.
2008: Monto Arnold S; Whitley Richard J
Seasonal and pandemic influenza: a 2007 update on challenges and solutions.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(7):1024-31.
2007: Victor John C; Monto Arnold S; Surdina Tatiyana Y; Suleimenova Saida Z; Vaughan Gilberto; Nainan Omana V; Favorov Michael O; Margolis Harold S; Bell Beth P
Hepatitis A vaccine versus immune globulin for postexposure prophylaxis.
The New England journal of medicine 2007;357(17):1685-94.
2007: Halloran M Elizabeth; Hayden Frederick G; Yang Yang; Longini Ira M; Monto Arnold S
Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials.
American journal of epidemiology 2007;165(2):212-21.
2006: Markel Howard; Stern Alexandra M; Navarro J Alexander; Michalsen Joseph R; Monto Arnold S; DiGiovanni Cleto
Nonpharmaceutical influenza mitigation strategies, US communities, 1918-1920 pandemic.
Emerging infectious diseases 2006;12(12):1961-4.
2006: Ohmit Suzanne E; Victor John C; Rotthoff Judy R; Teich Esther R; Truscon Rachel K; Baum Laura L; Rangarajan Bhavya; Newton Duane W; Boulton Matthew L; Monto Arnold S
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines.
The New England journal of medicine 2006;355(24):2513-22.
2006: Monto Arnold S; Comanor Lorraine; Shay David K; Thompson William W
Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness.
The Journal of infectious diseases 2006;194 Suppl 2():S92-7.
2006: Whitley Richard J; Monto Arnold S
Seasonal and pandemic influenza preparedness: a global threat.
The Journal of infectious diseases 2006;194 Suppl 2():S65-9.
2006: Whitley Richard J; Bartlett John; Hayden Frederick G; Pavia Andrew T; Tapper Michael; Monto Arnold S
Seasonal and pandemic influenza: recommendations for preparedness in the United States.
The Journal of infectious diseases 2006;194 Suppl 2():S155-61.
2006: Whitley Richard J; Monto Arnold S
Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.
The Journal of infectious diseases 2006;194 Suppl 2():S133-8.
2006: Englund Janet A; Walter Emmanuel B; Gbadebo Adepeju; Monto Arnold S; Zhu Yuwei; Neuzil Kathleen M
Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Pediatrics 2006;118(3):e579-85.
2006: Walter Emmanuel B; Neuzil Kathleen M; Zhu Yuwei; Fairchok Mary P; Gagliano Martha E; Monto Arnold S; Englund Janet A
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Pediatrics 2006;118(3):e570-8.
2006: Yen Hui-Ling; Hoffmann Erich; Taylor Garry; Scholtissek Christoph; Monto Arnold S; Webster Robert G; Govorkova Elena A
Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses.
Journal of virology 2006;80(17):8787-95.
2006: Ohmit Suzanne E; Monto Arnold S
Symptomatic predictors of influenza virus positivity in children during the influenza season.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(5):564-8.
2006: Monto Arnold S; McKimm-Breschkin Jennifer L; Macken Catherine; Hampson Alan W; Hay Alan; Klimov Alexander; Tashiro Masato; Webster Robert G; Aymard Michelle; Hayden Frederick G; Zambon Maria
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.
Antimicrobial agents and chemotherapy 2006;50(7):2395-402.
2006: Victor J C; Surdina T Y; Suleimeova S Z; Favorov M O; Bell B P; Monto A S
The increasing prominence of household transmission of hepatitis A in an area undergoing a shift in endemicity.
Epidemiology and infection 2006;134(3):492-7.
2006: Monto Arnold S
Antivirals for influenza in healthy adults.
Lancet 2006;367(9522):1571-2; author reply 1573.
2006: Victor J C; Surdina T Y; Suleimenova S Z; Favorov M O; Bell B P; Monto A S
Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies.
American journal of epidemiology 2006;163(3):204-10.
2006: Monto Arnold S
Vaccines and antiviral drugs in pandemic preparedness.
Emerging infectious diseases 2006;12(1):55-60.
2005: Cinti Sandro; Chenoweth Carol; Monto Arnold S
Preparing for pandemic influenza: should hospitals stockpile oseltamivir?
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2005;26(11):852-4.
2005: Yen Hui-Ling; Herlocher Louise M; Hoffmann Erich; Matrosovich Mikhail N; Monto Arnold S; Webster Robert G; Govorkova Elena A
Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.
Antimicrobial agents and chemotherapy 2005;49(10):4075-84.
2005: Yen Hui-Ling; Monto Arnold S; Webster Robert G; Govorkova Elena A
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice.
The Journal of infectious diseases 2005;192(4):665-72.
2005: Englund Janet A; Walter Emmanuel B; Fairchok Mary P; Monto Arnold S; Neuzil Kathleen M
A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children.
Pediatrics 2005;115(4):1039-47.
2005: Monto Arnold S
The threat of an avian influenza pandemic.
The New England journal of medicine 2005;352(4):323-5.
2005: Hayden Frederick; Klimov Alexander; Tashiro Masato; Hay Alan; Monto Amold; McKimm-Breschkin Jennifer; Macken Catherine; Hampson Alan; Webster Robert G; Amyard Michèle; Zambon Maria
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses.
Antiviral therapy 2005;10(8):873-7.
2004: Herlocher M Louise; Truscon Rachel; Elias Stephanie; Yen Hui-Ling; Roberts Noel A; Ohmit Suzanne E; Monto Arnold S
Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.
The Journal of infectious diseases 2004;190(9):1627-30.
2004: Monto Arnold S; Rotthoff Judy; Teich Esther; Herlocher M Louise; Truscon Rachel; Yen Hui-Ling; Elias Stephanie; Ohmit Suzanne E
Detection and control of influenza outbreaks in well-vaccinated nursing home populations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(4):459-64.
2004: Sperber Steven J; Shah Leena P; Gilbert Richard D; Ritchey Thomas W; Monto Arnold S
Echinacea purpurea for prevention of experimental rhinovirus colds.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(10):1367-71.
2004: Monto Arnold S
Occurrence of respiratory virus: time, place and person.
The Pediatric infectious disease journal 2004;23(1 Suppl):S58-64.
2003: Herlocher M Louise; Truscon Rachel; Fenton Rob; Klimov Alexander; Elias Stephanie; Ohmit Suzanne E; Monto Arnold S
Assessment of development of resistance to antivirals in the ferret model of influenza virus infection.
The Journal of infectious diseases 2003;188(9):1355-61.
2003: Monto Arnold S
Invited commentary: Use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy.
American journal of epidemiology 2003;158(4):312-5.
2003: Monto Arnold S
The role of antivirals in the control of influenza.
Vaccine 2003;21(16):1796-800.
2003: Fendrick A Mark; Monto Arnold S; Nightengale Brian; Sarnes Matthew
The economic burden of non-influenza-related viral respiratory tract infection in the United States.
Archives of internal medicine 2003;163(4):487-94.
2003: Monto Arnold S; Bramley Thomas J; Sarnes Matthew
Development of a predictive index for picornavirus infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(3):253-8.
2003: Loughlin Jeanne; Poulios Nick; Napalkov Pavel; Wegmüller Yann; Monto Arnold S
A study of influenza and influenza-related complications among children in a large US health insurance plan database.
PharmacoEconomics 2003;21(4):273-83.
2002: Monto Arnold S
The seasonality of rhinovirus infections and its implications for clinical recognition.
Clinical therapeutics 2002;24(12):1987-97.
2002: Monto Arnold S; Pichichero Michael E; Blanckenberg Steve J; Ruuskanen Olli; Cooper Chris; Fleming Douglas M; Kerr Caron
Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.
The Journal of infectious diseases 2002;186(11):1582-8.
2002: Herlocher M L; Carr J; Ives J; Elias S; Truscon R; Roberts N; Monto A S
Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets.
Antiviral research 2002;54(2):99-111.
2002: Monto Arnold S
Epidemiology of viral respiratory infections.
The American journal of medicine 2002;112 Suppl 6A():4S-12S.
2002: Blitz Susan G; Cram Peter; Chernew Michael E; Monto Arnold S; Fendrick A Mark
Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: what a difference a day makes.
The American journal of managed care 2002;8(3):221-7.
2001: Monto A S; Fendrick A M; Sarnes M W
Respiratory illness caused by picornavirus infection: a review of clinical outcomes.
Clinical therapeutics 2001;23(10):1615-27.
2001: Herlocher M L; Elias S; Truscon R; Harrison S; Mindell D; Simon C; Monto A S
Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus.
The Journal of infectious diseases 2001;184(5):542-6.
2001: Monto A S; Hornbuckle K; Ohmit S E
Influenza vaccine effectiveness among elderly nursing home residents: a cohort study.
American journal of epidemiology 2001;154(2):155-60.
2001: Cram P; Blitz S G; Monto A; Fendrick A M
Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies.
PharmacoEconomics 2001;19(3):223-30.
2000: Monto A S; Moult A B; Sharp S J
Effect of zanamivir on duration and resolution of influenza symptoms.
Clinical therapeutics 2000;22(11):1294-305.
2000: Monto A S; Gravenstein S; Elliott M; Colopy M; Schweinle J
Clinical signs and symptoms predicting influenza infection.
Archives of internal medicine 2000;160(21):3243-7.
2000: Hayden F G; Gubareva L V; Monto A S; Klein T C; Elliot M J; Hammond J M; Sharp S J; Ossi M J;
Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
The New England journal of medicine 2000;343(18):1282-9.
1999: Cram P; Blitz S G; Monto A; Fendrick A M
Diagnostic testing for influenza: review of current status and implications of newer treatment options.
The American journal of managed care 1999;5(12):1555-61; quiz 1562-3.
1999: Monto A S; Webster A; Keene O
Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis.
The Journal of antimicrobial chemotherapy 1999;44 Suppl B():23-9.
1999: Monto A S; Fleming D M; Henry D; de Groot R; Makela M; Klein T; Elliott M; Keene O N; Man C Y
Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
The Journal of infectious diseases 1999;180(2):254-61.
1999: Monto A S; Victor J C
Hepatitis A vaccine for secondary hepatitis A infection.
Lancet 1999;354(9175):341-2; author reply 342-3.
1999: Monto A S; Robinson D P; Herlocher M L; Hinson J M; Elliott M J; Crisp A
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
JAMA : the journal of the American Medical Association 1999;282(1):31-5.
1999: Monto A S
Interrupting the transmission of respiratory tract infections: theory and practice.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(2):200-4.
1999: Ohmit S E; Arden N H; Monto A S
Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic.
Journal of the American Geriatrics Society 1999;47(2):165-71.
1999: Monto A S
Individual and community impact of influenza.
PharmacoEconomics 1999;16 Suppl 1():1-6.
1998: Monto A S; Lehmann D
Acute respiratory infections (ARI) in children: prospects for prevention.
Vaccine 1998;16(16):1582-8.
1997: Monto A S
Prospects for pandemic influenza control with currently available vaccines and antivirals.
The Journal of infectious diseases 1997;176 Suppl 1():S32-7.
1996: Ohmit S E; Moler F W; Monto A S; Khan A S
Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection.
Journal of clinical epidemiology 1996;49(9):963-7.
1996: Monto A S
The clinical efficacy of influenza vaccination.
PharmacoEconomics 1996;9 Suppl 3():16-22; discussion 23-5.
1995: Ohmit S E; Monto A S
Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons.
International journal of epidemiology 1995;24(6):1240-8.
1995: Monto A S
Viral respiratory infections in the community: epidemiology, agents, and interventions.
The American journal of medicine 1995;99(6B):24S-27S.
1995: Monto A S; Ohmit S E; Hornbuckle K; Pearce C L
Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes.
Antimicrobial agents and chemotherapy 1995;39(10):2224-8.
1995: Ohmit S E; Furumoto-Dawson A; Monto A S; Fasano N
Influenza vaccine use among an elderly population in a community intervention.
American journal of preventive medicine 1995;11(4):271-6.
1995: Monto A S; Ohmit S E; Margulies J R; Talsma A
Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity.
American journal of epidemiology 1995;141(6):502-6.
1995: Arden N; Monto A S; Ohmit S E
Vaccine use and the risk of outbreaks in a sample of nursing homes during an influenza epidemic.
American journal of public health 1995;85(3):399-401.
1994: Monto A S
Using antiviral agents to control outbreaks of influenza A infection.
Geriatrics 1994;49(12):30-4.
1992: Monto A S; Arden N H
Implications of viral resistance to amantadine in control of influenza A.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(2):362-7; discussion 368-9.
1992: Foster D A; Talsma A; Furumoto-Dawson A; Ohmit S E; Margulies J R; Arden N H; Monto A S
Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly.
American journal of epidemiology 1992;136(3):296-307.
1991: Abdeljaber M H; Monto A S; Tilden R L; Schork M A; Tarwotjo I
The impact of vitamin A supplementation on morbidity: a randomized community intervention trial.
American journal of public health 1991;81(12):1654-6.
1990: Monto A S; Ohmit S
Respiratory syncytial virus in a community population: circulation of subgroups A and B since 1965.
The Journal of infectious diseases 1990;161(4):781-3.
1990: Sullivan K M; Monto A S; Foster D A
Antibody response to inactivated influenza vaccines of various antigenic concentrations.
The Journal of infectious diseases 1990;161(2):333-5.
1989: Koopman J S; Monto A S; Longini I M
The Tecumseh Study. XVI: Family and community sources of rotavirus infection.
American journal of epidemiology 1989;130(4):760-8.
1989: Koopman J S; Monto A S
The Tecumseh Study. XV: Rotavirus infection and pathogenicity.
American journal of epidemiology 1989;130(4):750-9.
1989: Monto A S; Schwartz S A; Albrecht J K
Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families.
Antimicrobial agents and chemotherapy 1989;33(3):387-90.
1988: Monto A S; Albrecht J K; Schwartz S A
Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon.
Antimicrobial agents and chemotherapy 1988;32(1):47-50.
1987: Monto A S; Bryan E R; Ohmit S
Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes.
The Journal of infectious diseases 1987;156(1):43-9.
1986: Monto A S; Koopman J S; Bryan E R
The Tecumseh Study of Illness. XIV. Occurrence of respiratory viruses, 1976-1981.
American journal of epidemiology 1986;124(3):359-67.
1986: Monto A S; Shope T C; Schwartz S A; Albrecht J K
Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection.
The Journal of infectious diseases 1986;154(1):128-33.
1985: Monto A S; Koopman J S; Longini I M
Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981.
American journal of epidemiology 1985;121(6):811-22.
1985: Koopman J S; Turkish V J; Monto A S
Infant formulas and gastrointestinal illness.
American journal of public health 1985;75(5):477-80.
1985: Miller F D; Monto A S; DeLong D C; Exelby A; Bryan E R; Srivastava S
Controlled trial of enviroxime against natural rhinovirus infections in a community.
Antimicrobial agents and chemotherapy 1985;27(1):102-6.
1984: Longini I M; Seaholm S K; Ackerman E; Koopman J S; Monto A S
Simulation studies of influenza epidemics: assessment of parameter estimation and sensitivity.
International journal of epidemiology 1984;13(4):496-501.
1984: Koopman J S; Turkisk V J; Monto A S; Thompson F E; Isaacson R E
Milk fat and gastrointestinal illness.
American journal of public health 1984;74(12):1371-3.
1984: Longini I M; Monto A S; Koopman J S
Statistical procedures for estimating the community probability of illness in family studies: rhinovirus and influenza.
International journal of epidemiology 1984;13(1):99-106.
1984: Koopman J S; Turkish V J; Monto A S; Gouvea V; Srivastava S; Isaacson R E
Patterns and etiology of diarrhea in three clinical settings.
American journal of epidemiology 1984;119(1):114-23.
1983: Monto A S; Koopman J S; Longini I M; Isaacson R E
The Tecumseh study. XII. Enteric agents in the community, 1976-1981.
The Journal of infectious diseases 1983;148(2):284-91.
1982: Longini I M; Koopman J S; Monto A S; Fox J P
Estimating household and community transmission parameters for influenza.
American journal of epidemiology 1982;115(5):736-51.
1982: Koopman J S; Eckert E A; Greenberg H B; Strohm B C; Isaacson R E; Monto A S
Norwalk virus enteric illness acquired by swimming exposure.
American journal of epidemiology 1982;115(2):173-7.
1981: Monto A S; Maassab H F; Bryan E R
Relative efficacy of embryonated eggs and cell culture for isolation of contemporary influenza viruses.
Journal of clinical microbiology 1981;13(1):233-5.
1980: Monto A S; Koopman J S
The Tecumseh Study. XI. Occurrence of acute enteric illness in the community.
American journal of epidemiology 1980;112(3):323-33.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Arnold Monto

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Geographic Areas

Phenomena

Concepts & Ideas

Physiology

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Arnold Monto (preview)

All Publications